Med LifeLTS:0RO5 71 9-Day RSI is 100.00 as of Jul. 11, 2026. GuruFocus rates LTS:0RO5 with a GF Score™ of 71/100 and a GF Value™ of lei1.40 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 698 Healthcare Providers & Services companies, Med Life ranks worse than 60.6% on this metric.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
As of today (2026-07-11), Med Life's 9-Day RSI is 100.00.
The industry rank for Med Life's 9-Day RSI or its related term are showing as below:
LTS:0RO5's 9-Day RSI is ranked worse than 60.6% of 698
companies
in the Healthcare Providers & Services industry
Industry Median: 50.38
vs LTS:0RO5: 100.00
Med Life (LTS:0RO5) 9-Day RSI Explanation
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
Med Life 9-Day RSI Related Terms
LTS:0RO5 vs HCA, THC, DVA: 9-Day RSI Comparison
For the Medical Care Facilities subindustry, Med Life's 9-Day RSI, along with its competitors' market caps and 9-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Med Life 9-Day RSI vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Med Life's 9-Day RSI distribution charts can be found below:
* The bar in red indicates where Med Life's 9-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Med Life (LTS:0RO5) has a 9-Day RSI of 100.00 as of Jul. 11, 2026. According to the industry distribution chart, Med Life ranks #423 out of 698 companies in the Healthcare Providers & Services industry, placing it in the top 60.6%.
Is Med Life's 9-Day RSI too high?
Med Life's current 9-Day RSI is 100.00. The Healthcare Providers & Services industry median 9-Day RSI is 50.38. Med Life's value of 100.00 is 98.5% above this industry median. Based on the distribution chart, Med Life ranks #423 out of 698 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Med Life has a GF Score™ of 71/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Med Life's 9-Day RSI compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Med Life ranks #423 out of 698 companies for 9-Day RSI. This places Med Life in the lower half of its industry. The industry median 9-Day RSI is 50.38. Med Life's value of 100.00 is 98.5% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 9-Day RSI for a Healthcare Providers & Services company?
The median 9-Day RSI among Healthcare Providers & Services companies is 50.38, based on 698 companies in the industry. Companies in the top quartile (top 25%) have a 9-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 9-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Med Life's current 9-Day RSI of 100.00 is 98.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 9-Day RSI mean?
A high 9-Day RSI can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median 9-Day RSI is 50.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Med Life's current 9-Day RSI is 100.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Med Life stock overvalued right now?
Based on GuruFocus' analysis, Med Life (LTS:0RO5) is currently considered Significantly Overvalued. The stock's GF Value™ is lei1.40, compared to a current price of lei11.38 — trading 712.5% above its estimated fair value. The current 9-Day RSI is 100.00 and 98.5% above the Healthcare Providers & Services industry median of 50.38. Med Life's overall GF Score™ is 71/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 9-Day RSI calculated?
9-Day RSI is calculated from a company's financial statements. For Med Life (LTS:0RO5), the current 9-Day RSI is 100.00 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Med Life (LTS:0RO5) Overvalued in 2026?
Based on GuruFocus' analysis, Med Life stock appears to be overvalued.
The current stock price of lei11.38 is trading 712.5% above its estimated GF Value™ of lei1.40.
GuruFocus considers Med Life to be Significantly Overvalued.
Key valuation signals for LTS:0RO5:
9-Day RSI: 100.00
GF Value™: lei1.40 vs. price of lei11.38 (712.5% above fair value)
Industry Position: 98.5% above the Healthcare Providers & Services median (#423 of 698)
No single metric tells the full story. See the LTS:0RO5 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Med Life SA is a healthcare provider in Romania. The Company's activity resides in the performance of healthcare services activities through medical centres with national coverage. It is engaged in the provision of rendering of medical services, rental of medical facilities and acquisition of materials and commodities. The company provides medical service through Hyper clinics in Arad, Bucharest, Braila, Brasov, Cluj, Constanta, Craiova, Galati, Iasi, Oradea, Ploiesti, Sibiu and Timisoara; Clinics, hospitals located in Bucharest, Arad, Sibiu, Brasov, Cluj and Ploiesti, Laboratories, Pharmacies and Dental Clinics.
71GF Score
Get the complete analysis for LTS:0RO5
9-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0RO5 has been successfully added to your 